Home | List of Topics | Diabetes/ Endocrinology/ Metabolism | Endocrinology
Hypercalcemia is an excessive amount of calcium in the blood.
Calcium is important in the body. It is an important part of the bone, and it exists as a charged particle called an ion in the blood and inside cells. Calcium is important to many body functions including bone formation, muscle contraction, nerve and brain function, and the release of hormones.
Parathyroid hormone (PTH) and vitamin D regulate calcium balance in the body. PTH is produced by the parathyroid glands -- four small glands located in the neck behind the thyroid gland. Vitamin D is obtained from exposure of skin to sunlight, and from dietary sources such as fortified dairy products, egg yolks, fish, and fortified cereals.
Primary hyperparathyroidism is the most common cause of hypercalcemia and is due to excess PTH. The drug lithium, used in treating bipolar disorder, may increase PTH release and cause hypercalcemia. A genetic mutation that affects the body's ability to regulate calcium is seen in familial hypocalciuric hypercalcemia (FHH), a benign (non-cancerous) condition.
Blood calcium can also be high despite low levels of PTH, however. Some malignant tumors (for example, lung cancers, breast cancer) produce PTH-related peptide (PTHrP) which increases blood calcium. Excess vitamin D (hypervitaminosis D) from diet or inflammatory diseases can also cause hypercalcemia. Kidney failure, adrenal gland failure, hyperthyroidism, prolonged immobilization, use of a class of diuretics called thiazides, and ingestion of massive amounts of calcium (milk-alkali syndrome) are other potential causes.
Hypercalcemia affects from 0.1 to 1% of the population. The widespread ability to measure blood calcium since the 1960s has improved detection of the condition, and today most patients with hypercalcemia have no symptoms. Women over the age of 50 are most likely to be hypercalcemic, usually due to primary hyperparathyroidism.
Skeletal:
Treatment is directed at the underlying cause of hypercalcemia whenever possible. In cases of hyperparathyroidism, surgery may be needed to remove the abnormal parathyroid gland and cure the hypercalcemia.
When hypercalcemia is mild and caused by primary hyperparathyroidism, patients may be followed closely by their doctor over time. A new medication named cinacalcet has been shown to lower calcium levels in the blood by reducing parathyroid hormone production.
Severe hypercalcemia causing symptoms and requiring hospitalization is treated aggressively with the following:
Prognosis depends on the underlying cause of hypercalcemia. Patients with mild hyperparathyroidism or hypercalcemia with a treatable cause (for example, primary hyperparathyroidism, dietary hypervitaminosis D) may not suffer complications from hypercalcemia.
Patients with hypercalcemia secondary to conditions such as cancer or granulomatous disease may have a poor prognosis due to the underlying disease itself rather than to the hypercalcemia. The complications of prolonged hypercalcemia are uncommon today.
Skeletal
Kidney
Gastrointestinal
Psychosocial
Contact your physician or health care provider if you have a family history of hypercalcemia, family history of hyperparathyroidism, or if symptoms of hypercalcemia occur.
Most causes of hypercalcemia cannot be prevented. Women over the age of 50 should see their health care provider regularly and have their blood calcium screened periodically.
Hypercalcemia from calcium and vitamin D supplements can be avoided by contacting your health care provider for advice if you are taking supplements without a prescription.
Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004; 69(2): 333-9.
Carroll MF. A practical approach to hypercalcemia. Am Fam Physician. 2003; 67(9): 959-66.
Ariyan CE. Assessment and management of patients with abnormal calcium. Crit Care Med. 2004; 32(4 Suppl): S146-54.
Review Date:5/12/2006
Reviewed By:Robert Hurd, MD, Department of Biology, College of Arts and Sciences, Xavier University, Cincinnati, OH. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.